Monday - June 22, 2026
Kirkland Advises Apogee Therapeutics on $10.9 Billion Sale to Abbvie
June 22, 2026
CHICAGO, Illinois, June 22 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, issued the following news release:

* * *

Kirkland Advises Apogee Therapeutics on $10.9 Billion Sale to Abbvie

*

Kirkland & Ellis advised Apogee Therapeutics (Nasdaq: APGE) on a definitive agreement under which AbbVie (NYSE: ABBV) will acquire Apogee and its diverse pipeline of multiple clinical-stage candidates in development across inflammatory and immun . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products